Division of Clinical Immunology and RheumatologyUniversity of Alabama at Birmingham, Center for Education and Research on Therapeutics on Musculoskeletal Disorders
Cite this article as:
Curtis, J.R. Osteoporos Int (2011) 22: 445. doi:10.1007/s00198-011-1710-2
Despite the many advances in scientific research over the last several decades, cutting edge technologies and therapeutics often take many years to find their way into widespread use. The dissemination and uptake of best practices into clinical care is sometimes a neglected component of research that is essential to improve the population’s health. Type 2 translational research, sometimes called “Proof in Practice Research,” seeks to maximize the yield of what has been learned from the bench and from carefully controlled clinical trials and to extend those benefits to a larger population. One aspect of type 2 translational research, sometimes called evidence implementation or implementation science, applies what has been learned about clinical medicine to achieve best practices across providers and health systems. This article describes evidence implementation as applied to osteoporosis care, drawing from several published or ongoing studies to illustrate challenges and potential solutions in improving the quality of osteoporosis care.
Bone mineral density testingEvidence implementationGroup randomized trialOsteoporosis